SCHEMBL31023978

SCHEMBL31023978

O=C(O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2ccc3c(c2)OCO3)CC1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.47
CYP3A4 P08684 8/20 0.45
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
FAAH O00519 1/20 0.41
TRPV1 Q8NER1 2/20 0.41
MAPT P10636 2/20 0.40
UBE2M P61081 1/20 0.40
DCUN1D1 Q96GG9 1/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31023754 0.90 ALDH1A1 (0.43) MGLLCYP3A4ALDH1A1LMNAFAAH
SCHEMBL31023722 0.85 MGLL (0.49) MGLLCYP3A4MAPTMEN1KMT2A
SCHEMBL31023784 0.84 SMN1; SMN2 (0.48) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL28919139 0.81 CYP3A4 (0.59) CYP3A4
SCHEMBL31023691 0.79 MGLL (0.45) MGLLCYP3A4ALDH1A1LMNAFAAH
SCHEMBL31023988 0.78 HTR2C (0.43) CYP3A4
SCHEMBL31023747 0.77 SCD5 (0.51) MGLLLMNAMAPTMEN1KMT2A
SCHEMBL31023933 0.77 MEN1 (0.55) MGLLLMNAMAPTMEN1KMT2A
SCHEMBL15094598 0.76 MGLL (0.67) MGLLALDH1A1LMNAFAAHMAPT
SCHEMBL21722935 0.74 CYP3A4 (0.47) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665718-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF Apogee Pharmaceuticals, Inc. (CA) 2025-12-24 EP disclosed
WO-2024168426-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2024-08-22 WO disclosed